Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Opinion in Lipidology
|
May 29, 2019
Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E Kosmas
American Journal of Therapeutics
|
December 9, 2014
New and Emerging LDL Cholesterol-Lowering Drugs
Constantine E Kosmas, William H Frishman
Expert Review of Endocrinology & Metabolism
|
December 11, 2023
Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?
Donatos Tsamoulis, Constantine E Kosmas, Loukianos S Rallidis
Expert Opinion on Drug Discovery
|
May 28, 2024
Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis
Donatos Tsamoulis, Loukianos S Rallidis, Constantine E Kosmas
Current Medicinal Chemistry
|
July 16, 2021
Environmental Factors Modifying HDL Functionality
Constantine E Kosmas, Andreas Sourlas, Eliscer Guzman, et al.
Cardiology in Review
|
May 28, 2013
Alpha-1 adrenoceptor-angiotensin II type 1 receptor cross-talk and its relevance in clinical medicine
Timothy J Vittorio, Marat Fudim, Gabriel Wagman, et al.
Clinical Medicine Insights. Cardiology
|
March 22, 2016
CETP Inhibition: Past Failures and Future Hopes
Constantine E Kosmas, Eddy DeJesus, Digna Rosario, et al.
Cardiology in Review
|
October 13, 2012
Evolution of the chronic congestive heart failure paradigm
John A Savino, Constantine E Kosmas, Gabriel Wagman, et al.
Annals of Translational Medicine
|
January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fraction
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Cardiology in Review
|
January 21, 2014
Inflammation in coronary artery disease
Georgios Christodoulidis, Timothy J Vittorio, Marat Fudim, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Opinion in Lipidology
|
May 29, 2019
Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E Kosmas
American Journal of Therapeutics
|
December 9, 2014
New and Emerging LDL Cholesterol-Lowering Drugs
Constantine E Kosmas, William H Frishman
Expert Review of Endocrinology & Metabolism
|
December 11, 2023
Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?
Donatos Tsamoulis, Constantine E Kosmas, Loukianos S Rallidis
Expert Opinion on Drug Discovery
|
May 28, 2024
Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis
Donatos Tsamoulis, Loukianos S Rallidis, Constantine E Kosmas
Current Medicinal Chemistry
|
July 16, 2021
Environmental Factors Modifying HDL Functionality
Constantine E Kosmas, Andreas Sourlas, Eliscer Guzman, et al.
Cardiology in Review
|
May 28, 2013
Alpha-1 adrenoceptor-angiotensin II type 1 receptor cross-talk and its relevance in clinical medicine
Timothy J Vittorio, Marat Fudim, Gabriel Wagman, et al.
Clinical Medicine Insights. Cardiology
|
March 22, 2016
CETP Inhibition: Past Failures and Future Hopes
Constantine E Kosmas, Eddy DeJesus, Digna Rosario, et al.
Cardiology in Review
|
October 13, 2012
Evolution of the chronic congestive heart failure paradigm
John A Savino, Constantine E Kosmas, Gabriel Wagman, et al.
Annals of Translational Medicine
|
January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fraction
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Cardiology in Review
|
January 21, 2014
Inflammation in coronary artery disease
Georgios Christodoulidis, Timothy J Vittorio, Marat Fudim, et al.
Page
of 6